- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about PTGX
Recent news which mentions PTGX
From Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
April 26, 2022
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 26, 2022
From Benzinga
18 Stocks Moving in Tuesday's Pre-Market Session
April 26, 2022
From Benzinga
Protagonist Therapeutics Topline Data from Phase 2 IDEAL Study of PN-943 (450 mg BID) Miss Primary Endpoint
April 25, 2022
Tickers
PTGX
From Benzinga
From Benzinga
51 Biggest Movers From Thursday
April 18, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 14, 2022
From Benzinga
From Benzinga
From InvestorPlace
FDA Intends To Revoke Protagonist Therapeutics' Rusfertide Breakthrough Tag In Rare Form Of Blood Cancer
April 14, 2022
Tickers
PTGX
From Benzinga
From Benzinga
3 Desirable Drug Stocks With Very Promising Pipelines
February 16, 2022
Tags
XBI
SDGR
NASDAQ:HRMY,NASDAQ:SDGR,NASDAQ:PTGX,NYSEARCA:XBI,NASDAQ:SNY,NYSE:BMY,NASDAQ:AGIO,NYSE:JNJ
From InvestorPlace
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
December 03, 2021
From Benzinga
What 9 Analyst Ratings Have To Say About Protagonist Therapeutics
November 15, 2021
Tickers
PTGX
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
Why Protagonist Therapeutics Stock Skyrocketed 80.2% Last Month
November 08, 2021
Tickers
PTGX
From Motley Fool
5 Short Squeeze Candidates To Watch: Progenity Tops List Again, Augmented Reality Play WiMi Hologram Joins List
November 01, 2021
From Benzinga
From InvestorPlace
5 Short Squeeze Candidates To Watch: Progenity, Digital Brands Top List Again, SPAC AGC Joins Ahead Of Merger
October 25, 2021
From Benzinga
From Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
From Benzinga
Ten stocks worth watching next week
October 16, 2021
From AC Investor Blog
What 10 Analyst Ratings Have To Say About Protagonist Therapeutics
October 13, 2021
Tickers
PTGX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.